Viatris Inc. (VTRS)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for VTRS is $20.49, 9.8% above the last close of $18.66 on Oct 16, 2026; targets range from $11.60 to $26.03. Rating consensus: Buy.
Snapshot
- P/E—
- P/E vs sector—
- P/E vs own—
- Target upside+9.8%
- ConsensusBuy
- Market cap$21.43B
- FCF yield+8.7%
- InsidersNone in 90d
- Earnings in20d
- News
Why it moved
Viatris Inc. (VTRS) rose 2.4% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.8%. Most of the move is specific to VTRS.
1 story on the day (30-day average 0.5).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $18.66 · +91.2% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI69
- Support-8.8%
- Resistance—
- Off 52w high0.0%
- Off ATH-69.3%
- 52w range$18.66
- Bollingerabove upper
- MACD0.05
- ATR+2.7%
- Volume1.0x
Analyst price targets
7 firms with a target in the last 12 months · last close $18.66 · as of Oct 16, 2026
Strong buy 1 · Buy 6 · Hold 4 · Sell 0 · Strong sell 1
Revenue and free cash flow
Q2 FY2026: Revenue +4.9% year over year, free cash flow 8.8% of revenue, operating margin 0.2%.
| Q2 FY2026 | Jun 30, 2026 | $3.76B | -0.10 | $329M | 38.8% | 0.2% | -3.2% |
| Q1 FY2026 | Mar 31, 2026 | $3.52B | 0.15 | $348M | 32.9% | -2.3% | 5.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.7B | -0.30 | $551M | 30.6% | -7.2% | -9.2% |
| Q3 FY2025 | Sep 30, 2025 | $3.76B | -0.11 | $645M | 36.8% | 6.7% | -3.4% |
| Q2 FY2025 | Jun 30, 2025 | $3.58B | 0.00 | $166M | 37.2% | 6.5% | -0.1% |
| Q1 FY2025 | Mar 31, 2025 | $3.25B | -2.55 | $459M | 35.7% | -88.6% | -93.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.53B | -0.43 | $329M | 34.4% | -5.1% | -14.6% |
| Q3 FY2024 | Sep 30, 2024 | $3.75B | 0.08 | $741M | 38.9% | 6.0% | 2.5% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $79.38 | +1.2% | -45.2% | +24.2% | 13.1 | $32.78B | |
| 2 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 3 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B | |
| 4 |  | $113.07 | -0.2% | -13.0% | +13.6% | 14.4 | $22.92B | |
| 5 |  | $222.66 | -0.7% | -16.4% | +24.2% | 27.2 | $21.71B | |
| 6 | | $18.66 | +2.4% | 0.0% | +9.8% | — | $21.43B | |
| 7 |  | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | |
| 8 |  | $152.64 | -1.3% | -3.0% | -18.2% | 72.7 | $17.03B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.